Jnana Therapeutics' Series A Round

Jnana Therapeutics raised a round of funding on December 14, 2017.

Jnana Therapeutics is building a drug discovery platform dedicated to targeting the solute carrier (SLC) family of transporters, the cell's metabolic gates. Jnana's proprietary small molecule platform…

Articles about Jnana Therapeutics' Series A Round: